NAS10028,945+0.02%S&P7,552−0.45%GOLD$4,410+0.51%BTC$76,720+0.75%VIX15.47−12.65%live tape · as of 17:00 UTC
The Screen · Industrials · Specialty Business Services
ABM Industries Incorporated
ABM · the NYSE · USD · Market cap $2.9B · 113,000 employees
ABM Industries Incorporated, through its subsidiaries, engages in the provision of facility maintenance, engineering and infrastructure solutions in the United States and internationally.
Screened 2026-09-15 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
ABM Industries Incorporated holds its Markup at $49.91. Consolidating, no directional conviction, held for 4 days.
As held on the ledger · 2026-09-15
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 4 days
Price at the screen
$49.91
Valuation
18.08 trailing · 11.47 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.67
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
31.85%
Below 33%
Interest-bearing debt is just 31.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
29.89%
Below 49%
Money owed to the company is 29.9% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 35.2% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +8% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Keeping Offices Running But Numbers Tell Caution
Think of the people who keep skyscrapers clean, fix the lifts and maintain the power after everyone else has gone home. ABM does that work across offices, factories and airports. The business is steady, ethical screen clears without issue, yet the opportunity rating sits at none because the returns do not clear our bar.
Revenue is rising 8 percent, the shares trade at 10.9 times forward earnings and sit well below our $65 fair value. Still, a 2 percent profit margin and 9 percent return on equity leave little room for error or reinvestment. Analyst targets cluster around $52, confirming the market sees only modest upside rather than a clear bargain.
Low margins and an unknown moat make this look like a classic cyclical service trap where earnings can flatten quickly when clients cut costs. Currency moves or a slowdown in commercial real estate would hit fast. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ABM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-08Markdown$47.77+0.0%Entry 17
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-06Markdown$47.77+0.0%Entry 16
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-05Markdown$47.77+0.0%Entry 15
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-03Markdown$47.77+0.0%Entry 14
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-02Markdown$47.77+0.0%Entry 13
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markdown$47.77+0.0%Entry 12
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markdown$47.77+0.0%Entry 11
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markdown$47.77+0.0%Entry 10
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markdown$47.77+0.0%Entry 9
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Markdown$47.77+0.0%Entry 8
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
